210P Prognostic Value of HER2-low Status in Metastatic Breast Cancer (mbc) Patients Treated with I Line CDK 4/6 Inhibitors (CDK 4/6i): A Real-Word Analysis of the GIM14/BIOMETA Study
ESMO Open(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined